Melissa B. Epperly - 17 Jul 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: Director
Issuer ticker: ROIV
Reported as of: 17 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jul 2026, 21:00:17 UTC
Prior SEC filing: 01 Jul 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Melissa Epperly

Key filing fact

Melissa B. Epperly filed Form 4 for Roivant Sciences Ltd. (ROIV) on 21 Jul 2026.

Key facts

This page summarizes Melissa B. Epperly's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2026, 21:00.

Change

Previous filing in this sequence was filed on 01 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001807359 Primary reporting owner

Epperly Melissa B,

Relationship: Director
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Melissa Epperly
Signature date: 21 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Award

Transaction value
Shares: +543
Change %: +3.3%
Price: $0.000000^*
Shares after: 17,017
Date: 17 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.

SEC remarks

Exhibit 24 - Power of Attorney